Combining oral anticoagulation and antiplatelet therapies: appropriate patient selection
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
http://link.springer.com/article/10.1007/s11239-018-1635-0/fulltext.html
Reference51 articles.
1. Hira RS, Kennedy K, Nambi V et al (2015) Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry’s Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol 65(2):111–121
2. Barnes GD, Lucas E, Alexander GC, Goldberger ZD (2015) National trends in ambulatory oral anticoagulant use. Am J Med 128(12):1300-5.e2
3. Mackman N (2008) Triggers, targets and treatments for thrombosis. Nature 451(7181):914–918
4. De Caterina R, Ammentorp B, Darius H et al (2014) Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. Heart 100:1625–1635
5. Bauersachs R, Berkowitz SD, Brenner B et al (2010) Rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 363(26):2499–2510
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Multi-enzyme mimetic iridium nanozymes-based thrombus microenvironment-modulated nanoplatform for enhanced thrombolytic therapy;Chemical Engineering Journal;2023-08
2. Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update;Journal of NeuroInterventional Surgery;2023-05-15
3. Association between obesity and short- and medium-term mortality in critically ill patients with atrial fibrillation: a retrospective cohort study;BMC Cardiovascular Disorders;2023-03-23
4. Antithrombotic Treatment and Its Association with Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients;Journal of Cardiovascular Development and Disease;2022-10-25
5. Important Risk Factors in Patients with Nonvalvular Atrial Fibrillation Taking Dabigatran Using Integrated Machine Learning Scheme—A Post Hoc Analysis;Journal of Personalized Medicine;2022-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3